Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit
|
|
- Buck Hamilton
- 5 years ago
- Views:
Transcription
1 Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit Executive Summary Background Antibiotic resistance poses a significant threat to public health, as antibiotics underpin routine medical practice. Broad-spectrum antibiotics (e.g. co-amoxiclav, quinolones and cephalosporins) should be avoided when narrowspectrum antibiotics remain effective because they increase the risk of Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium difficile and resistant urinary tract infections. In the UK, 80% of antibiotic prescribing occurs in primary care, with over half for respiratory tract infections. The inappropriate use of antibiotics is related to bacterial resistance. The UK five-year antimicrobial resistance strategy aims to slow the development and spread of resistance. 1 Guidance by Public Health England (PHE) makes clear recommendations about when broad-spectrum antibiotics should be prescribed. By reviewing the use of these antibiotics in primary care retrospectively, clinicians can assess if this guidance is being followed and, where appropriate, make specific changes to clinical practice. 2 Key Findings 1. 71% of patients on prophylactic antibiotic therapy were on long-term treatment and of these 45% were highlighted for a review by practice pharmacists. Most patients were on long-term prophylactic treatment with cephalosporins for the prevention of UTIs % of patients who were treated with a cephalosporin for a UTI were also sensitive to either nitrofurantoin or trimethoprim, which should have been prescribed first line. In addition for 39% of patients, cephalexin was prescribed first line as empirical treatment over trimethoprim and nitrofurantoin. 3. Co-amoxiclav was only prescribed in line with PHE guidance in 28% of patients. In 43% of patients prescribed co-amoxiclav, this was not the appropriate choice in line with PHE guidance. In 20% of patients the choice and duration were not in line with PHE guidance, primarily where 7 days treatment was prescribed when a 5- day course was recommended % of prescribing of quinolones was in line with PHE guidance, however this apparent higher percentage of compliance compared with prescribing of co-amoxiclav and cephalosporins was due to 100% compliance of ofloxacin prescribing with PHE guidance. Quinolones were not the appropriate choice of antibiotic for 27% of patients. Recommendations Practice pharmacists to re-emphasise to GPs PHE guidance with respect to the choice of prescribing of first line ciprofloxacin, cephalosporins and co-amoxiclav and refer to further NICE CKS guidance for further detail on specific indications listed. Approximately half of patients on long term prophylactic antibiotic therapy, predominantly for UTIs and treated with cephalosporins, require a review of treatment with the outcome of the review documented. City and Hackney CCG to develop more focused audits for prescribing antibiotics as highlighted from this audit. Suggested areas are long term prescribing of antibiotics for prophylaxis and prescribing of antibiotics for UTIs. Clear communication is required from secondary care regarding the duration of prophylactic therapy for UTIs and patients should be reviewed every 6 months. Gain agreement locally between primary and secondary care for choice of antibiotic prescribing for common indications and appropriate doses, frequencies and durations of treatment in line with PHE guidance, as currently there is a wide variation. In addition discussion of referral or further treatment options when primary antibiotic courses are unsuccessful. 1
2 INTRODUCTION Antibiotic resistance poses a significant threat to public health, as antibiotics underpin routine medical practice. Broad-spectrum antibiotics (e.g. co-amoxiclav, quinolones and cephalosporins) should be avoided when narrowspectrum antibiotics remain effective because they increase the risk of Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium difficile and resistant urinary tract infections. In the UK, 80% of antibiotic prescribing occurs in primary care, with over half for respiratory tract infections. The inappropriate use of antibiotics is related to bacterial resistance. The UK five-year antimicrobial resistance strategy aims to slow the development and spread of resistance. 1 Quinolones are recommended first line by Public Health England (PHE) only in limited situations such as in acute pyelonephritis, acute prostatitis or pelvic inflammatory disease. Resistance to quinolones is increasing at a considerable rate (for example, quinolone-resistant Neisseria gonorrhoeae), affecting all the quinolones. Guidance by PHE makes clear recommendations about when quinolones, co-amoxiclav, and cephalosporins should be prescribed. By reviewing the use of these antibiotics in primary care retrospectively, clinicians can assess if this guidance is being followed and, where appropriate, make specific changes to clinical practice. 2 Patients on long-term antibiotic therapy should also be included in this audit to review appropriateness of ongoing therapy and antibiotic choice. To review the prescribing of cephalosporins, quinolones and co-amoxiclav in line with PHE guidance. AIM METHOD To ensure that all strengths and brand names are included. The following were included: Quinolones Cephalosporins Co-Amoxiclav Ciprofloxacin (Ciproxin ) Levofloxacin (Tavanic ) Moxifloxacin (Avelox ) Nalidixic Acid Norfloxacin Ofloxacin (Tarivid ) Cefaclor (Distaclor, Distaclor MR ) Cefadroxil Cefalexin (Ceporex, Keflex ) Cefixime (Suprax ) Cefradine Cefuroxime (Zinnat ) Co-amoxiclav (Augmentin ) 1. Up to 30 patients who were prescribed a cephalosporin, a quinolone or co-amoxiclav from 1 st November to 31 st December 2016 were randomly selected for audit from each practice. 2. The electronic data collection form was completed for each patient, using the guidance from PHE as a reference point. 3. Prescribing for each practice was due to be re-evaluated in February to March epact data from 1 st February to 31 st March 2017 will be analysed to indicate any changes in prescribing patterns of cephalosporins, quinolones and co-amoxiclav since the baseline audit. 2
3 STANDARDS No. CRITERIA CCG TARGET Average 1 Co-amoxiclav is prescribed in line with PHE guidance.* 28% 100% 2 Cephalosporins are prescribed in line with PHE guidance.* 17% 100% 3 Quinolones are prescribed in line with PHE guidance.* 55% 100% 4 Patients prescribed a quinolone, co-amoxiclav or cephalosporin for long-term 70% 100% prophylaxis, have been reviewed for appropriateness of antibiotic choice since initiation of treatment. (Actual data based on whether patient has had a medication review in the last 12 months) *(If prescribing is outside of PHE recommendations, then it complies with recommendations from secondary care, microbiology or is in line with CKS guidance). RESULTS The broad-spectrum antibiotic prescribing audits were undertaken by PSPs and submitted for all 43 GP practices. One practice has a unique patient population and was therefore excluded. Data was collected for 807 patients. Table 1. Total Number of Broad Spectrum Antibiotics Prescribed Antibiotic prescribed Prescribed for Treatment Prescribed for Prophylaxis Total Co-amoxiclav (41%) Quinolones (25%) Cephalosporins (34%) Total 720 (89%) 87 (11%) 807 Compliance with each of the 4 standards is outlined below. STANDARD 1 (TARGET = 100%) Yes No Unknown Co-Amoxiclav is prescribed in line with PHE guidance* *(If prescribing is outside of PHE recommendations, then it complies with recommendations from secondary care, microbiology or is in line with CKS guidance). 40 (28%) 104 (72%) Total number of patients prescribed co-amoxiclav Prescribed in line with PHE guidance PHE Indication Non PHE Indication 138 NA Total patients were prescribed co-amoxiclav for an indication outside of the PHE guidance and for 23 (17%) of these patients, treatment was recommended by secondary care. 2 3
4 Co-amoxiclav Co-amoxiclav Prescribed for Indications within PHE Guidance Total no. of Additional information patients Prescribed in line with PHE guidance 34 Prescribing complies with recommendations from secondary care/microbiology or is in line with CKS guidance 6 Choice of antibiotic is not in line with PHE guidance 63 Choice and duration of antibiotic are not in line with PHE 29 Choice of antibiotics appropriate, but dose/frequency/duration are not in line with PHE guidance 10 Prescribed multiple courses of the same antibiotic 2 Unknown if appropriate, lack of additional information 2 Total 146 STANDARD 2 (TARGET = 100%) Yes No Unknown Cephalosporins are prescribed in line with PHE guidance* *(If prescribing is outside of PHE recommendations, then it complies with Used first line for many patients 2 MSU samples not sent off 1 patient had 8 courses of co-amoxiclav 35 (17%) 174 (83%) 3 recommendations from secondary care, microbiology or is in line with CKS guidance). Prescribing for 9 (56%) out of 16 patients, prescribed a cephalosporin for an indication outside of the PHE guidance, complied with recommendations from secondary care, microbiology or was in line with CKS guidance. A follow-up letter from secondary care suggested stopping treatment for one patient, which was subsequently stopped by the GP on recommendation from the practice pharmacist undertaking the audit. Total number of patients prescribed a cephalosporin Prescribed in line with PHE guidance Urinary Tract Infection (UTI) Treatment Other PHE Indication 20 1 Non PHE Indication 16 NA Total Breakdown of Cephalosporin prescribing for the treatment of UTI Findings Total no. of patients Prescribed in line with PHE guidance 31 Prescribing complies with recommendations from secondary care/microbiology 3 Microbiology sensitivities to nitrofurantoin/trimethoprim 21 Nitrofurantoin/trimethoprim should have been used first/second line 75 Choice and duration of antibiotic treatment is not in line with PHE guidance 38 Choice of antibiotic okay, but dose, frequency or duration not in line with PHE guidance 21 Unknown if appropriate, lack of additional information 3 Total 192 Additional information 1 patient had 8 courses 4
5 STANDARD 3 (TARGET = 100%) Yes No Unknown Quinolones are prescribed in line with PHE guidance* *(If prescribing is outside of PHE recommendations, then it complies with recommendations from secondary care, microbiology or is in line with CKS guidance). Quinolones Total number of patients prescribed a quinolone Prescribed in line with PHE guidance PHE Indication Non PHE Indication 47 NA Total Prescribing for 13(28%) out of the 47 patients, prescribed a quinolone for an indication outside of the PHE guidance, complied with recommendations from secondary care, microbiology or was in line with CKS guidance. It was difficult to ascertain the severity of the condition for some patients and therefore to know if prescribing was appropriate due to a lack of information. Quinolones prescribed for an indication in PHE Guidance Quinolone Number patients In line with PHE Guidance Ciprofloxacin Levofloxacin 2 0 Ofloxacin Total (55%) 69 (45%) 6 Ofloxacin was prescribed for Pelvic Inflammatory Disease and Epididymitis and 100% of prescribing was in line with PHE guidance. Treatment of UTIs and upper and lower respiratory tract infections accounted for 55% of ciprofloxacin prescribing. Quinolones Total number of patients Prescribing in line with PHE guidance 61 Prescribing complies with recommendations from secondary care/microbiology or is in line with CKS guidance. 25 Additional information 3 patients have had multiple Choice of antibiotic is not in line with PHE guidance courses of quinolones and 44 need referring Choice and duration of antibiotic are not in line with PHE guidance 6 Choice of antibiotic is appropriate, but the dose/frequency/duration is not in line with PHE guidance 16 2 MSUs not sent off Multiple courses of antibiotic have been prescribed for the same patient 3 Unknown if appropriate, lack of additional information 6 Total patients were prescribed 3 courses in a short period of time 5
6 STANDARD 4 (TARGET = 100%) Yes No Patients prescribed a quinolone, co-amoxiclav or cephalosporin for long-term prophylaxis, have been reviewed for appropriateness of antibiotic choice since initiation of treatment. (Actual data based on whether patient has had a medication review in the last 12 months) 61 (70%) 26 (30%) Of the 87 patients on prophylactic broad-spectrum antibiotics, 61 (70%) had had a medication review in the last 12 months. 62 (71%) patients are on long-term treatment with broad-spectrum antibiotics, ranging from over 6 months to 13 years. Of concern may be that nearly a fifth of patients on prophylactic antibiotics have been taking them for 3 or more years with 11% having taken them for 6 or more years. Antibiotic UTI Prophylaxis Other Indication Total Cephalexin Ciprofloxacin Co-amoxiclav Cefradine Cefuroxime Total 76 (87%) 11 (13%) patients were on prophylactic antibiotic treatment with a quinolone, co-amoxiclav or a cephalosporin. 76 (87%) patients were on broad spectrum antibiotics for the prophylaxis of Urinary Tract Infection (UTI) and 67 (77%) patients were treated with cephalexin for UTI prophylaxis. PHE guidance was not applicable for 11 patients, as the indication documented as to why they were on prophylactic antibiotics was not listed in the PHE guidance. 6 (55%) of these patients were under specialist care. UTI Prophylaxis Prescribing of a broad spectrum antibiotic was recommended by secondary care for 37 (43%) of patients. Prescribing is not in line with PHE guidance for UTI prophylaxis for 19 (22%) patients. Duration of Treatment with Prophylactic Antimicrobials 0-3m 6m- 1yr 1-2 yrs 3-5yrs 6-10yrs 11-13yrs Long term Unknown Ciprofloxacin Cephalosporins Co-amoxiclav Total (45%) patients on long term treatment need a review as indicated by practice pharmacists in the additional notes section when completing the data collection form. Treatment may have been initiated by a specialist for many of these patients and the need for continued treatment may not have been considered to be reviewed. Practice pharmacists have raised with GPs where a review of treatment is required. 1 patient will be switched to nitrofurantoin and another has been recommended to stop prophylactic therapy, but is reluctant to do so. Discussion and Conclusion The broad spectrum antibiotic audit showed that co-amoxiclav was only prescribed in line with PHE guidance in 28% of patients. In 43% of patients prescribed co-amoxiclav, this was not the appropriate choice in line with PHE guidance. In 20% of patients the choice and duration was not in line with PHE guidance, primarily where 7 days treatment was prescribed when a 5 day course was recommended. Co-amoxiclav was commonly prescribed first line or second line for lower and upper respiratory tract infections, when first line treatment options do not appear to have been considered. 6
7 A limitation to auditing antibiotic prescribing in line with PHE guidance was when there was treatment failure and establishing why a certain treatment was not suitable for a patient and what the next step was as second line treatment options were not always recommended or included in the PHE guidance. The NICE Clinical Knowledge Summaries (CKS) are useful to refer to where appropriate and relevant, however without additional patient information, it was difficult to ascertain in some cases the exact rationale for treatment. Practice pharmacists did confirm that some GPs refer to local antibiotic guidelines from Homerton University Hospital. Co-amoxiclav was also prescribed for numerous indications outside of PHE guidance making it difficult to audit appropriateness of treatment and this was also outside the scope of this audit. 84% of cephalosporins prescribed for treatment of infections were to treat UTIs. If treatment of a UTI is indicated, then nitrofurantoin or trimethoprim are recommended as first line options. 11% of patients who were treated with a cephalosporin were also sensitive to either nitrofurantoin or trimethoprim, which should have been prescribed first line. In addition for 39% of patients, cephalexin was prescribed first line as empirical treatment over trimethoprim and nitrofurantoin. In 20% of patients the choice and duration of cephalosporin prescribed was not in line with PHE guidance. 55% of prescribing of quinolones was in line with PHE guidance, however this higher percentage of compliance compared with prescribing of co-amoxiclav and cephalosporins was due to 100% compliance of ofloxacin prescribing with PHE guidance. Quinolones were not the appropriate choice of antibiotic for 27% of patients and in 10% the quinolones were an appropriate choice, but the dose, frequency or duration of treatment was not in line with PHE guidance. 70% of patients prescribed a quinolone, co-amoxiclav or cephalosporin for long-term antibiotic prophylaxis had had a medication review in the past 12 months. However this does not necessarily mean than the appropriateness of antibiotic choice has been reviewed since initiation of treatment. 71% of patients on prophylactic antibiotic therapy were on long-term treatment, classified as on therapy for more than 6 months and of these 45% were highlighted for a review by practice pharmacists. Most patients were on long term prophylactic treatment for the prevention of UTIs. There is weak evidence from a Cochrane systematic review that continuous antibiotic use reduces the recurrence of urinary tract infections more than placebo but they are associated with more adverse effects There is insufficient direct evidence to prefer any particular antibiotic over another for prophylaxis of a UTI. Trimethoprim and nitrofurantoin are recommended options for prophylaxis of recurrent UTI because they are narrow spectrum antibiotics and are generally preferred over broad spectrum antibiotics due to concerns over increasing the risk of Clostridium difficile, MRSA, and resistant UTIs. Both trimethoprim and nitrofurantoin are licensed for the prophylaxis of recurrent UTI. Most patients on prophylactic UTI therapy with cephalexin in this audit were prescribed a dose of 250mg once daily. Cephalexin is not licensed for UTI prophylaxis, however we are aware that it is commonly prescribed for this indication. The British National Formulary recommends a dose of 125mg each night. 3 Recommendations Practice pharmacists to re-emphasise to GPs PHE guidance with respect to the choice of prescribing of first line ciprofloxacin, cephalosporins and co-amoxiclav and refer to further NICE CKS guidance for further detail on specific indications listed. Approximately half of patients on long term prophylactic antibiotic therapy, predominantly for UTIs and treated with cephalosporins, require a review of treatment with the outcome of the review documented. City and Hackney CCG to develop more focused audits for prescribing antibiotics as highlighted from this audit. Suggested areas are long term prescribing of antibiotics for prophylaxis and prescribing of antibiotics for UTIs. Clear communication is required from secondary care regarding the duration of prophylactic therapy for UTIs and patients should be reviewed every 6 months. 7
8 Gain agreement locally between primary and secondary care for choice of antibiotic prescribing for common indications and appropriate doses, frequencies and durations of treatment in line with PHE guidance, as currently there is a wide variation. In addition discussion of referral or further treatment options when primary antibiotic courses are unsuccessful. References 1. TARGET antibiotics toolkit; Royal College of General Practitioners 2. Management of infection guidance for primary care for consultation and local adaptation; Public Health England; July Clinical Knowledge Summaries; July 2015; 8
Volume 1; Number 7 November 2007
Volume 1; Number 7 November 2007 CONTENTS Page 1 Page 3 Guidance on the Use of Antibacterial Drugs in Lincolnshire Primary Care: Winter 2007/8 NICE Clinical Guideline 54: Urinary Tract Infection in Children
More informationPromoting Appropriate Antimicrobial Prescribing in Secondary Care
Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR
More informationPrescribing Quality Scheme 2017/18
Prescribing Quality Scheme 2017/18 In line with national policy and the Quality Premium, we are continuing to promote good antimicrobial stewardship and, therefore, include this element in an incentive
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationAntimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley
Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationWhat can we learn from point prevalence surveys? Mark Gilchrist Consultant Pharmacist Infectious Diseases
What can we learn from point prevalence surveys? Mark Gilchrist Consultant Pharmacist Infectious Diseases Imperial College Healthcare NHS Trust mark.gilchrist@imperial.nhs.uk Outline Placing point prevalence
More informationQuality indicators and outcomes in the devolved nations Scotland
Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationDr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust
Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated
More informationANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT
ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT CLINICAL GUIDELINES ID TAG Title: Prepared by Specialty / Division: Directorate: Antimicrobial Stewardship
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationWomen s Antimicrobial Guidelines Summary
Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University
More informationUTI Dr S Mathijs Department of Pharmacology
UTI Dr S Mathijs Department of Pharmacology Introduction Responsible for > 7 million consultations annually 15% of all antibiotic prescriptions 40% of all hospital acquired infections Significant burden
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationMembers are asked to: Support the uptake and development of the AWMSG National Audit: Focus on Antibiotic Prescribing.
Enclosure No: Agenda Item No: Author: Contact: 7/AWMSG/0215 11 Review of the AWMSG National Audit: Focus on Antibiotic Prescribing 2013 2015 All Wales Prescribing Advisory Group (AWPAG) Lead: TL Lewis
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationPart 2c and 2d CQUIN 2018/19 webinar, 22 February 2018 Answers to questions asked
Part 2c and 2d CQUIN 2018/19 webinar, 22 February 2018 Answers to questions asked 1. What is the weighting in the CQUIN between the consultant review of antibiotics and the infection pharmacist? This section
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationCLINICAL AUDIT. Prescribing amoxicillin clavulanate appropriately
CLINICAL AUDIT Prescribing amoxicillin clavulanate appropriately Valid to September 2018 bpac nz better medicin e Background Amoxicillin clavulanate is a broad spectrum antibiotic used in primary care
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationWhat s happening across the UK with antimicrobial prescribing quality indicators?
What s happening across the UK with antimicrobial prescribing quality indicators? Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Antimicrobial Management Team Network
More informationCork and Kerry SARI Newsletter; Vol. 2 (2), December 2006
Cork and SARI Newsletter; Vol. 2 (2), December 6 Item Type Newsletter Authors Murray, Deirdre;O'Connor, Nuala;Condon, Rosalind Download date 31/1/18 15:27:31 Link to Item http://hdl.handle.net/1147/67296
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationANTIMICROBIALS PRESCRIBING STRATEGY
Directorate of Operations Clinical Support Services Diagnostic Services Pharmacy ANTIMICROBIALS PRESCRIBING STRATEGY Reference: DCM021 Version: 2.0 This version issued: 25/04/16 Result of last review:
More informationWhat is an Antibiotic Stewardship Program?
What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent
More informationTrust Guideline for the Management of: Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology
Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology A Clinical Guideline For use in: By: For: Division responsible for document: Key words: Interventional Radiology Prescribers
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationUrinary Tract Infection Workshop
Urinary Tract Infection Workshop Diagnosis, sampling, antibiotic selection, recurrence, prophylaxis Nick Francis, Robin Howe, Harry Ahmed Outline Diagnosis and sampling Nick 10 min Choice of antibiotic
More informationPOINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine
POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals Koen Magerman Working group Hospital Medicine Background Strategic plan By means of a point prevalence survey and internal audits
More informationNICE consultation on key therapeutic topics: June Comments and responses: September Key Therapeutic Topic
NICE consultation on key therapeutic topics: June 2014 Comments and responses: September 2014 Key Therapeutic Topic Laxatives NHS Southern Derbyshire CCG What is the purpose or benefit of this topic? Laxatives
More informationnumber Done by Corrected by Doctor
number 28 Done by Dina Yaseen Corrected by حسام أبو عوض Doctor مالك الزحلف Cephalosporins -Cephalosporins are β-lactam antibiotics isolated from a strain of Streptomyces. -They are bactericidal and work
More informationAntibiotic Stewardship in the LTC Setting
Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship
More informationAntibiotic Stewardship: The Facility Role and Implementation. Tim Cozad, LPN, Lead LTC Health Facilities Surveyor
Antibiotic Stewardship: The Facility Role and Implementation Tim Cozad, LPN, Lead LTC Health Facilities Surveyor Phase II CMS Regulatory Changes Current information available includes: New Survey Process
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More informationDr Steve Holden Consultant Microbiologist Nottingham University Hospitals NHS Trust
Dr Steve Holden Consultant Microbiologist Nottingham University Hospitals NHS Trust Clinical Case 38 yrold man Renal replacement (CAPD) since 2011 Unexplained ESRF Visited Pakistan for 3 months end of
More informationSURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS
SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationAuthor s: Clinical Standards Group and Effectiveness Sub-Board
Trust Antibiotic Policy for the Management of Common Infections in Accident and Emergency and Cromer Minor Injuries Unit (Paediatrics) Accident and Emergency, Norfolk and Norwich and For Use in: Cromer
More informationPrescribing Management
Prescribing Management Aim - To consistently promote and improve the safe, clinical and cost effectiveness of prescribing Margaret Maskrey, Lead Clinical Pharmacist, Inverclyde CHCP Why is prescribing
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationmoxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering
moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering 05 November 2010 The Scottish Medicines Consortium (SMC) has completed its assessment of the above
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationSt. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report
St. Joseph s General Hospital Vegreville and Mary Immaculate Care Centre Antimicrobial Stewardship Report January to June 217 Introduction Antibiotics are among the most commonly prescribed medications
More informationVolume 2; Number 16 October 2008
Volume 2; Number 16 October 2008 What s new this month NHS Lincolnshire have launched a public information campaign designed to raise public awareness of the risks associated with the inappropriate use
More informationHalting Infections in Long Term Care
Results of HALT Study 2013 Halting Infections in Long Term Care HALT Seminar Novemeber 2014 DR Nuala O Connor ICGP Lead HCAI AMR DR Bartley Cryan Consultant microbiologist CUH Dr Paul Gallagher Consultant
More informationModels for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist
Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist philip.howard2@nhs.net Twitter: @AntibioticLeeds United Kingdom of England, Scotland, Wales & Northern Ireland
More informationake National Point Prevalence Survey of Healthcare Associated Infections, Device usage and Antimicrobial use in Long-Term Care Facilities 2017 HALT-3
ake National Point Prevalence Survey of Healthcare Associated Infections, Device usage and Antimicrobial use in Long-Term Care Facilities 2017 HALT-3 Wales HCAI and AMR Programme The Healthcare Associated
More informationAntimicrobial practice. Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice
Journal of Antimicrobial Chemotherapy (2003) 51, 379 384 DOI: 10.1093/jac/dkg032 Advance Access publication 6 January 2003 Antimicrobial practice Laboratory antibiotic susceptibility reporting and antibiotic
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix O 3 December 2014 Final version Commissioned
More informationINFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: DEC 2015
More informationQuality and Safety Committee
SUMMARY REPORT Quality and Safety Committee ABM University Health Board Meeting On 20 TH OCTOBER 2016 Subject Prepared by Approved & Presented by Purpose Big Fight Campaign AGENDA ITEM: 2.2 Debra Woolley
More informationAntimicrobial Stewardship. October 2012
Antimicrobial Stewardship October 2012 Rising Antimicrobial Resistance Methicillin resistant staphylococcus aureus (MRSA) Vancomycin resistant enterococci (VRE) MDR and extremely drug resistant (XDR TB)
More informationAntimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016
Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting
More informationHealthcare-associated Infections and Antimicrobial Use Prevalence Survey
Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Shamima Sharmin, M.B.B.S., MSc, MPH Emerging Infections Program New Mexico Department of Health Agenda Recognize healthcare-associated
More informationSECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products
SECTION 3A Criteria for Optional Special Authorization of Select Drug Products Section 3A Criteria for Optional Special Authorization of Select Drug Products CRITERIA FOR OPTIONAL SPECIAL AUTHORIZATION
More informationIDENTIFICATION: PROCESS: Waging the War against C. difficile Radical Multidisciplinary Approaches From a Community Hospital
Waging the War against C. difficile Radical Multidisciplinary Approaches From a Community Hospital Organization Name: St. Joseph Medical Center Type: Acute Care Hospital Contact Person: Leigh Chapman RN,
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationWELSH HEALTH CIRCULAR
WELSH HEALTH CIRCULAR WHC/2018/020 Issue Date: 4 May 2018 STATUS: ACTION & INFORMATION CATEGORY: QUALITY AND SAFETY Title: AMR IMPROVEMENT GOALS & HCAI REDUCTION EXPECTATIONS BY MARCH 2019: PRIMARY & SECONDARY
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationWho should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3
Antibiotic Prophylaxis in Cranial Neurosurgery Antibiotic Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationINFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: APRIL
More informationThe trinity of infection management: United Kingdom coalition statement
* The trinity of infection management: United Kingdom coalition statement This coalition statement, on behalf of our organizations (the UK Sepsis Trust, Royal College of Nursing, Infection Prevention Society,
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationGuidelines on prescribing antibiotics. For physicians and others in Denmark
Guidelines on prescribing antibiotics 2013 For physicians and others in Denmark Guidelines on prescribing antibiotics For physicians and others in Denmark 2013 by the Danish Health and Medicines Authority.
More informationUpdated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007
Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007 1 Ongoing data from CDC 's Gonococcal Isolate Surveillance Project (GISP), including
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationAntimicrobial Stewardship in Scotland
Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationNHS Dumfries And Galloway. Surgical Prophylaxis Guidelines
NHS Dumfries And Galloway Surgical Prophylaxis Guidelines The aim of surgical prophylaxis is to reduce rates of surgical site and health-care associated infections and so reduce surgical morbidity and
More informationCommunity-Acquired Pneumonia: Severity scoring and compliance to BTS guidelines. Julie Harris Antibiotic Pharmacist Hywel Dda Healthboard
Community-Acquired Pneumonia: Severity scoring and compliance to BTS guidelines Julie Harris Antibiotic Pharmacist Hywel Dda Healthboard Plan Background BTS guidelines Differences in opinion Measures introduced
More informationImpact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England
Impact of NHS England Quality Indicators on Antimicrobial Resistance Professor Alan Johnson National Infection Service Public Health England A Risk Assessment of Antibiotic Pan-Drug Resistance in the UK:
More informationReceived: Accepted: Access this article online Website: Quick Response Code:
Indian Journal of Drugs, 2016, 4(3), 69-74 ISSN: 2348-1684 STUDY ON UTILIZATION PATTERN OF ANTIBIOTICS AT A PRIVATE CORPORATE HOSPITAL B. Chitra Department of Pharmacy Practice, College of Pharmacy, Sri
More informationProtocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland
Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland Version 1.0 23 December 2011 General enquiries and contact details This is the first version (1.0) of the Protocol
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationAdvances in Antimicrobial Stewardship (AMS) at University Hospital Southampton
Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology Federation of Infection Societies 1 st December,
More informationIntroduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
More informationAntibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
More informationMicrobiology : antimicrobial drugs. Sheet 11. Ali abualhija
Microbiology : antimicrobial drugs Sheet 11 Ali abualhija return to our topic antimicrobial drugs, we have finished major group of antimicrobial drugs which associated with inhibition of protein synthesis
More informationVolume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.
Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines
More informationThe Nevada Adult Outpatient Empiric Prescribing Guidelines (2017)
The Nevada Adult Outpatient Empiric Prescribing Guidelines (2017) Background These empiric prescriber guidelines were produced by the AntiMicrobial Stewardship Summit (AMSS) series led by the University
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationManagement of uncomplicated urinary tract infection Robert Townsend MSc, MB ChB, DTM&H, MRCPath
Drug review UTI Management of uncomplicated urinary tract infection Robert Townsend MSc, MB ChB, DTM&H, MRCPath Skyline Imaging Ltd Urinary tract infections account for a significant proportion of GP consultations
More informationrates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group
Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies
More informationTREAT Steward. Antimicrobial Stewardship software with personalized decision support
TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationDATA COLLECTION SECTION BY FRONTLINE TEAM. Patient Identifier/ Medical Record number (for facility use only)
Assessment of Appropriateness of ICU Antibiotics (Patient Level Sheet) **Note this is intended for internal purposes only. Please do not return to PQC.** For this assessment, inappropriate antibiotic use
More information